News Agency
Men's Weekly

Positive BNC210 7-Day Dosing Pharmacokinetic Study Exceeds Blood Exposure Projected for Phase 2b PTSD Trial

  • Written by PR Newswire
  • BNC210 novel oral tablet formulation (900 mg given twice daily) exceeds blood exposure projected for upcoming Phase 2b PTSD trial
  • BNC210 Phase 2b PTSD trial on target for start in mid-2021 with final dose selected

ADELAIDE, Australia, Feb. 22, 2021 /PRNewswire/ -- Bionomics Limited (ASX: BNO, OTCQB: BNOEF, Germany: AU000000BNO5), a global,...

Read more: Positive BNC210 7-Day Dosing Pharmacokinetic Study Exceeds Blood Exposure Projected for Phase 2b...

How Often Should You Visit the Dentist? Here’s What Experts Say

When it comes to having a healthy smile, perhaps the most frequently asked question is, "How frequently should I go to the dentist?" Although there's a rule of thumb that says visit the dentist every six months, the truth isn't... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion